<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00981877</url>
  </required_header>
  <id_info>
    <org_study_id>protrota2007</org_study_id>
    <nct_id>NCT00981877</nct_id>
  </id_info>
  <brief_title>Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children</brief_title>
  <official_title>Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children: Randomized Double-blind, Controlled Trial Using Two Different Preparations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Pediatrico Albina de Patino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Nutrición y Tecnología de los Alimentos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centro Pediatrico Albina de Patino</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of probiotics in rotavirus acute&#xD;
      diarrhea in children. The investigators will compare the effect of two different probiotics&#xD;
      products.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute diarrhea remains being the second most frequent infectious condition in children,&#xD;
      producing a high number of admissions yearly. In children below one year of age, rotavirus&#xD;
      represents the main etiologic agent, both in developed and developing countries. In Bolivia,&#xD;
      acute diarrhea affects about 30% of the group below 5 years of age. Probiotics appear as one&#xD;
      of the alternatives currently under discussion. Also, evidence available suggests that&#xD;
      probiotics shorten the time of diarrhea and therefore the time of rotavirus excretion. In&#xD;
      daily practice, we are often limited by the type and number of probiotics products locally&#xD;
      available; moreover, information about combined products is scarce. With this in mind, in&#xD;
      this study we compared the efficacy of two commercially available products.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of diarrhea</measure>
    <time_frame>within the first 72 hours during hospitalization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of fever</measure>
    <time_frame>the first 72 hours during hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of vomiting</measure>
    <time_frame>the first 72 hours during hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>4 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Diarrhea</condition>
  <condition>Rotavirus Infection</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive S. Boulardii Probiotic and Oral rehydration as needed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive a mixed Probiotic preparation and oral rehydration as needed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This group will receive a placebo, and oral rehydration as needed</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GB (Florestor)</intervention_name>
    <description>S. Boulardii preparation of 1 gram twice daily for 5 days</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Florestor, Bioflora</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GRALB</intervention_name>
    <description>mixed probiotic preparation 1 gram twice daily for 5 days.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Probiotik, mixed probiotic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GC (placebo)</intervention_name>
    <description>Placebo 1 gram twice daily for 5 days.</description>
    <arm_group_label>3</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Positive stool sample for rotavirus test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe malnourishment&#xD;
&#xD;
          -  Severe dehydration&#xD;
&#xD;
          -  Use of antibiotics, probiotics or nitazoxanide 2 weeks before admission&#xD;
&#xD;
          -  Systemic infections&#xD;
&#xD;
          -  Severe chronic disease&#xD;
&#xD;
          -  Mixed enteric infections besides rotavirus&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>23 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard M Soria, MD</last_name>
    <role>Study Director</role>
    <affiliation>Centro Pediatrico Albina Patino</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giuseppe E Grandy, Md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro Pediatrico Albina Patino - Instituto de Nutricion y Tecnologia de los Alimentos</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centro Pediatrico Albina Patino</name>
      <address>
        <city>Cochabamba</city>
        <country>Bolivia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bolivia</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <study_first_submitted>September 18, 2009</study_first_submitted>
  <study_first_submitted_qc>September 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2009</study_first_posted>
  <last_update_submitted>September 21, 2009</last_update_submitted>
  <last_update_submitted_qc>September 21, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2009</last_update_posted>
  <responsible_party>
    <name_title>Giuseppe Grandy Aranda</name_title>
    <organization>Centro Pediatrico Albina de Patino/ Departamento de Gastroenterologia y Nutricion</organization>
  </responsible_party>
  <keyword>acute diarrhea</keyword>
  <keyword>rotavirus</keyword>
  <keyword>probiotic</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rotavirus Infections</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

